Glycosylation pathways are determined at many levels from the genome to the proteome and by the environment of cells in culture. Glycans have an influence on the safety and efficacy of many biological drugs, so it is necessary to understand the outcome that is relevant to the mode of action of the product. So what is the best process monitoring and control strategies? Session: Case Study - Variations in Glycosylation of Biopharmaceuticals: Approaches to Controlling the Pathways and Analyzing Glycans
Speaker: Pauline M. Rudd, Ph.D., NIBRT Research Professor, Dublin-Oxford Glycobiology Laboratory, NIBRT, Ireland
Want to learn more about the many possibilities for manipulating glycosylation pathways and the monitoring the intervention? Join us October 21-23 in Washington, D.C. for IBC's Inaugural Product and Process Variants & Impurities event. To learn more, download our agenda.
As a reader of this blog, you’ll receive 15% off the standard rate when using code XB13193BLOG to register. We look forward to seeing you this fall!
|
Share this article with your social network, just click below to share now!
|
|
|
No comments :
Post a Comment